Inhibiting de novo lipogenesis identifies a therapeutic vulnerability in therapy-resistant colorectal cancer.
Jog E, Jainarayanan AK, La Ferlita A, Chakraborty A, Dalwai A, Yahya S, Shivashankar A, Choudhary BS, Chandramouli A, Kazi M, Jain D, Khapare N, B A, Khan BK, Gera P, Patil P, Thorat R, Verma N, Sehgal L, Saklani A, Kamat SS, Dalal SN, Chaudhary N.
Jog E, et al. Among authors: chakraborty a.
Redox Biol. 2024 Dec 11;79:103458. doi: 10.1016/j.redox.2024.103458. Online ahead of print.
Redox Biol. 2024.
PMID: 39705849
Free article.